SK952002A3 - L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases - Google Patents

L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases Download PDF

Info

Publication number
SK952002A3
SK952002A3 SK95-2002A SK952002A SK952002A3 SK 952002 A3 SK952002 A3 SK 952002A3 SK 952002 A SK952002 A SK 952002A SK 952002 A3 SK952002 A3 SK 952002A3
Authority
SK
Slovakia
Prior art keywords
carnitine
propionyl
acetyl
pharmacologically acceptable
acid
Prior art date
Application number
SK95-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of SK952002A3 publication Critical patent/SK952002A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
SK95-2002A 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases SK952002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000483A IT1306179B1 (it) 1999-07-28 1999-07-28 Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
PCT/IT2000/000313 WO2001007039A2 (en) 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Publications (1)

Publication Number Publication Date
SK952002A3 true SK952002A3 (en) 2002-06-04

Family

ID=11406910

Family Applications (1)

Application Number Title Priority Date Filing Date
SK95-2002A SK952002A3 (en) 1999-07-28 2000-07-25 L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases

Country Status (20)

Country Link
US (2) US6653349B1 (it)
EP (1) EP1200077B1 (it)
AR (1) AR024981A1 (it)
AT (1) ATE314064T1 (it)
AU (1) AU779094B2 (it)
CA (1) CA2378724C (it)
CZ (1) CZ20024A3 (it)
DE (1) DE60025215T2 (it)
DK (1) DK1200077T3 (it)
ES (1) ES2254206T3 (it)
HU (1) HU229185B1 (it)
IL (1) IL147410A0 (it)
IT (1) IT1306179B1 (it)
MX (1) MXPA02000911A (it)
NO (1) NO20020369L (it)
PL (1) PL208961B1 (it)
SK (1) SK952002A3 (it)
TN (1) TNSN00163A1 (it)
TR (1) TR200200224T2 (it)
WO (1) WO2001007039A2 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011977B2 (en) * 1999-01-30 2006-03-14 Sigma-Tau Pharmaceuticals, Inc. Quantification of carnitine levels in dialysis patients
US7238531B2 (en) * 1999-01-30 2007-07-03 Pediatrix Screening, Inc. Method for interpreting tandem mass spectrometry data for clinical diagnosis
US7297545B2 (en) * 1999-01-30 2007-11-20 Pediatrix Screening, Inc. Clinical method for the genetic screening of newborns using tandem mass spectrometry and internal standards therefor
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
US7709539B2 (en) * 2004-08-11 2010-05-04 Chang Gung University Therapeutic use of resveratrol for hyperglycemia
US20060153934A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and magnesium
WO2007022344A2 (en) * 2005-08-17 2007-02-22 Hill's Pet Nutrition, Inc. Methods and compositions for the preventioin and treatment of kidney disease
ES2385169B1 (es) * 2010-12-22 2013-09-23 Servicio Andaluz De Salud Uso de la l-carnitina y sus composiciones, para el tratamiento y la prevención del daño renal.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0514928B1 (en) * 1991-05-24 1997-08-20 Wakamoto Pharmaceutical Co., Ltd. Method of diagnosing renal diseases by detecting albumin fragments
IT1277147B1 (it) * 1995-01-20 1997-11-04 Sigma Tau Ind Farmaceuti Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
IT1291113B1 (it) 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
IT1295408B1 (it) * 1997-10-03 1999-05-12 Sigma Tau Ind Farmaceuti Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo
IT1306179B1 (it) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.

Also Published As

Publication number Publication date
EP1200077A2 (en) 2002-05-02
PL354412A1 (en) 2004-01-12
ES2254206T3 (es) 2006-06-16
CA2378724A1 (en) 2001-02-01
HUP0202314A2 (en) 2002-10-28
EP1200077B1 (en) 2005-12-28
ITRM990483A0 (it) 1999-07-28
WO2001007039A2 (en) 2001-02-01
ITRM990483A1 (it) 2001-01-28
MXPA02000911A (es) 2002-10-23
AU6469200A (en) 2001-02-13
CZ20024A3 (cs) 2002-06-12
US7585896B2 (en) 2009-09-08
DE60025215T2 (de) 2006-07-13
DK1200077T3 (da) 2006-04-24
TNSN00163A1 (fr) 2005-11-10
TR200200224T2 (tr) 2002-08-21
IT1306179B1 (it) 2001-05-30
US6653349B1 (en) 2003-11-25
HU229185B1 (en) 2013-09-30
NO20020369L (no) 2002-03-21
WO2001007039A3 (en) 2001-03-29
PL208961B1 (pl) 2011-06-30
IL147410A0 (en) 2002-08-14
ATE314064T1 (de) 2006-01-15
AU779094B2 (en) 2005-01-06
DE60025215D1 (de) 2006-02-02
US20040057994A1 (en) 2004-03-25
NO20020369D0 (no) 2002-01-23
HUP0202314A3 (en) 2003-03-28
AR024981A1 (es) 2002-11-06
CA2378724C (en) 2008-10-14

Similar Documents

Publication Publication Date Title
US20030206895A1 (en) Antioxidant composition comprising propionyl L-carnitine and a flavonoid against throm-bosis and atherosclerosis
JPH027572B2 (it)
US6306392B1 (en) Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
CZ2001920A3 (cs) Kombinace karnitinů a resveratrolu k prevenci nebo léčbě poruch mozku a poruch spojených se stárnutím
PL194177B1 (pl) Kompozycja zawierająca acetylo-L-karnitynę i jej zastosowania
SK952002A3 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
KR100560097B1 (ko) 알콜중독자에게는 알콜 금단(禁斷) 증상과 음주욕구를 억제하고, 그리고 건강한 사람에게는 과음을 예방하는 약제조성물
SK4052002A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
CA2350220C (en) Antioxidant composition comprising propionyl l-carnitine and a flavonoid against thrombosis and atherosclerosis
PL204745B1 (pl) Kompozycja kombinowana do zapobiegania i/lub leczenia chorób spowodowanych niewłaściwym metabolizmem lipidów, zawierająca propionylo- L-karnitynę i chitosan
AU2001241031B2 (en) Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents
SK12402002A3 (sk) Kompozícia pre prevenciu a/alebo liečenie cievnych ochorení obsahujúca propionyl L-karnitín a koenzým Q10
AU2001241031A1 (en) Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents
TW200841827A (en) A nutritional supplement for adjustment of blood pressure and protection of cardio-vascular and cerebro-vascular systems
MXPA01004752A (en) Antioxidant composition comprising propionyl l-carnitine and a flavonoid against thrombosis and atherosclerosis